PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.

HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

HONG KONG,March 1,2025-- Neusoft Institute Guangdong,a member of Neutech Group Limited,has successfully acquired the land use rights for a new 140,000-square-meter plot in Nanhai District,Foshan City,

HANGZHOU,China,March 2,2025-- HIKMICRO,the leading pioneer of technology exploration in the hunting market,unveiled its vision for the future at the IWA Outdoor Classics 2025 show in Nuremburg. HIKMIC

BARCELONA,Spain,March 3,2025-- Huawei Cloud Commercial Vehicle Autonomous Driving Cloud Service (CVADCS) is thrilled to announce its debut at the Mobile World Congress (MWC) 2025,showcasing pioneering

Governments should prioritise pro-investment policies to accelerate network expansion and strengthen digital economies

Empowering future leaders with essential skills to combat climate change HONG KONG,March 3,2025-- AXA Hong Kong and Macau("AXA") launched the AXA Climate School in 2022,aimingto empower youn

SHENZHEN,China,March 3,2025-- UBTECH has successfully conducted the world\'s first collaborative practical training program for humanoid robots at ZEEKR\'s 5G Intelligent Factory,where multiple humano

First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI antibiotics in a germ-free mouse model

BEIJING,March 3,2025-- A news report fromchinadaily.com.cn： A panoramic view of the skyscrapers of Tianhe district. [Photo/VCG]